4
Total investments
1
Early stage
1
Mid stage
0
Late stage
25y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2018
Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery.
We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential.
The insight we provide facilitates the screening of compounds at speed and at scale to iterate medicinal chemistry, understand pharmacokinetics/pharmacodynamics (PK/PD) disconnects and build better models to define therapeutic windows.
You can email at info@enzymlogic.com to request further information on Enzymlogic’s drug discovery services and partnering information.
#BindingKinetics #drugdiscovery #pharmaceuticals #biotechnology
Member of the Board
Nov 2011
Agencias de España es la primera asociación de empresas independientes del sector del marketing y la comunicación.
Member of the Board
Jan 2001
Adigital is the Spanish Association for the Digital Economy.
It is an organization of innovative and transformative companies that create and work for the development of the economy based on the Internet, the Digital Media and New Technologies.
Adigital is composed of more than 500 large companies, SMEs and startups, from very different sectors, united by a common goal: to create in Spain and Europe an optimal environment for the development and growth of the digital economy as a means to build a more competitive, efficient and productive society.
To achieve this, he works in areas such as electronic commerce, digital content, marketing and digital communication, digital competences, collaborative economy, on demand and access, data protection and privacy, and public policies and regulation.
Experience · 13 entries
All (13)
Investments (4)
Founder (5)
Board (3)
2024
Founding Partner
Jun 2024
Forbes House nace en el corazón financiero de la capital y llevará su reputación a un espacio físico referente.
2022
Founder & CEO
Jan 2022
Jungle es un ecosistema de agencias creativas y de diseño. Alimentamos la creatividad para transformar las empresas y contribuir a la evolución de la sociedad. Ayudamos a nuestros clientes en su proceso de transformación aplicando la creatividad en toda su cadena de valor con una oferta integrada de estrategia, consultoría y diseño estratégico, tecnología, publicidad, contenidos, producción digital, diseño de productos y servicios, comunicación y relaciones públicas.
-
Jungle is an ecosystem of creative & design agencies. We nurture creativity to transform companies and contribute to the evolution of society. We help our clients in their transformation process by applying creativity throughout their entire value chain with an integrated offer of strategy, consulting and strategic design, tech, advertising, content, digital production, product and service design, communication, and public relations.
2018
P
PS21
Founder&CEO
Oct 2018
Investor
Jul 2018
Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery.
We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential.
The insight we provide facilitates the screening of compounds at speed and at scale to iterate medicinal chemistry, understand pharmacokinetics/pharmacodynamics (PK/PD) disconnects and build better models to define therapeutic windows.
You can email at info@enzymlogic.com to request further information on Enzymlogic’s drug discovery services and partnering information.
#BindingKinetics #drugdiscovery #pharmaceuticals #biotechnology
2016
R
Partner
Jan 2016
dommo.x y dmntia crean Randm, compañía que integra lo mejor de una agencia creativa y una productora.
Randm se presenta bajo la premisa de un nuevo consumidor que ya no consume contenidos como antes, que se encuentra sumido en la era de la random culture, donde lo único que importa es el presente. Su objetivo es cubrir esta necesidad de instantaneidad, para construir marcas que quieran introducirse en esta nueva cultura y formar parte de ella, acercando a los millennials tanto a grandes firmas como a start-ups o empresas que busquen un nuevo modelo de agencia en el que la creatividad y la producción se fusionan en una sola. Su filosofía de trabajo se basa en la rapidez, en la integración de la idea creativa en el proceso de producción y en la eficiencia de costes.
Randm ofrece tres servicios principales:
** (Un)branded content. Enfocado principalmente en millennials.
** Creativity+production. Ideal para startups.
** Producción. Servicios de productora.
Show all 13 entries ↓
Investment activity
2001–2018 · 4 investments
Recent (last 2 years)Earlier